IGC Pharma, Inc. (FRA:IGS1)
0.2560
-0.0100 (-3.76%)
At close: Jan 9, 2026
IGC Pharma Market Cap
IGC Pharma has a market cap or net worth of €24.74 million as of January 12, 2026. Its market cap has decreased by -11.14% in one year.
Market Cap
24.74M
Enterprise Value
23.89M
Revenue
942.64K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.26
Market Cap Chart
Since April 13, 2006, IGC Pharma's market cap has decreased from 63.61M to 24.74M, a decrease of -61.11%. That is a compound annual growth rate of -4.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 24.74M | 11.14% |
| Dec 31, 2025 | 22.26M | -11.45% |
| Dec 31, 2024 | 25.14M | 55.63% |
| Dec 29, 2023 | 16.15M | 2.25% |
| Dec 30, 2022 | 15.80M | -63.97% |
| Dec 31, 2021 | 43.83M | -16.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.94B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.49B |
| Deutsche Bank Aktiengesellschaft | 63.01B |